miR-142-3p acts as an essential modulator of neutrophil development in zebrafish

被引:51
|
作者
Fan, Hong-Bo [1 ,2 ,3 ,4 ]
Liu, Yi-Jie [1 ,2 ,3 ,5 ]
Wang, Lei [1 ,2 ,3 ,4 ]
Du, Ting-Ting [1 ,2 ,3 ,4 ]
Dong, Mei [1 ,2 ,3 ,4 ]
Gao, Li [1 ,2 ,3 ,4 ]
Meng, Zhao-Zheng [1 ,2 ,3 ,4 ]
Jin, Yi [1 ,2 ,3 ,4 ]
Chen, Yi [1 ,2 ,3 ,4 ]
Deng, Min [1 ,2 ,3 ,4 ]
Yang, Huang-Tian [1 ,2 ,3 ,4 ]
Jing, Qing [1 ,2 ,3 ,4 ]
Gu, Ai-Hua [6 ]
Liu, Ting-Xi [1 ,2 ,3 ,4 ]
Zhou, Yong [1 ,2 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, State Key Lab Med Genom, Shanghai 200025, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Dev & Dis, Shanghai 200025, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol, RuiJin Hosp, Shanghai 200030, Peoples R China
[5] Shanghai Jiao Tong Univ, Dept Lab Med, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China
[6] Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Sch Publ Hlth, Nanjing 210029, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
ZINC-FINGER NUCLEASES; COLLAGEN-INDUCED ARTHRITIS; TARGETED GENE DISRUPTION; DEFICIENT MICE; IN-VIVO; CELL PROLIFERATION; DIFFERENTIATION; EXPRESSION; MICRORNAS; RECEPTOR;
D O I
10.1182/blood-2013-12-545012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neutrophils play critical roles in vertebrate innate immune responses. As an emerging regulator in normal myelopoiesis, the precise roles of microRNA in the development of neutrophils have yet to be clarified. Using zinc-finger nucleases, we have successfully generated heritable mutations in miR-142a and miR-142b and showed that hematopoietic-specific miR-142-3p is completely deleted in miR-142 double mutant zebrafish. The lack of miR-142-3p resulted in aberrant reduction and hypermaturation of neutrophils in definitive myelopoiesis, as well as impaired inflammatory migration of neutrophils in the fetal stage. Furthermore, the adult myelopoiesis in the miR-142-3p-deficient zebrafish was also affected, producing irregular hypermature neutrophils with increased cell size and a decreased nucleocytoplasmic ratio. Additionally, miR-142-3p-deficient zebrafish are expected to develop a chronic failure of myelopoiesis with age. Transcriptome analysis showed an aberrant activation of the interferon gamma (IFN-gamma) signaling pathway in myelomonocytes after miR-142-3p deletion. We found that the reduced number and hypermaturation of neutrophils caused by loss of miR-142-3p was mainly mediated by the abnormally activated IFN-g signaling, especially the upregulation of stat1a and irf1b. Taken together, we uncovered a novel role of miR-142-3p in maintaining normal neutrophil development and maturation.
引用
收藏
页码:1320 / 1330
页数:11
相关论文
共 50 条
  • [31] miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia
    Wang, Fang
    Wang, Xiao-Shuang
    Yang, Gui-Hua
    Zhai, Peng-Fei
    Xiao, Zhen
    Xia, Liang-Yu
    Chen, Li-Rong
    Wang, Yu
    Wang, Xiao-Zhong
    Bi, Lai-Xi
    Liu, Nian
    Yu, Yang
    Gao, Da
    Huang, Bin-Tao
    Wang, Jing
    Zhou, Dao-Bin
    Gong, Jia-Nan
    Zhao, Hua-Lu
    Bi, Xiu-Hua
    Yu, Jia
    Zhang, Jun-Wu
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (03) : 2713 - 2722
  • [32] miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia
    Fang Wang
    Xiao-Shuang Wang
    Gui-Hua Yang
    Peng-Fei Zhai
    Zhen Xiao
    Liang-Yu Xia
    Li-Rong Chen
    Yu Wang
    Xiao-Zhong Wang
    Lai-Xi Bi
    Nian Liu
    Yang Yu
    Da Gao
    Bin-Tao Huang
    Jing Wang
    Dao-Bin Zhou
    Jia-Nan Gong
    Hua-Lu Zhao
    Xiu-Hua Bi
    Jia Yu
    Jun-Wu Zhang
    Molecular Biology Reports, 2012, 39 : 2713 - 2722
  • [33] miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation
    Mandolesi, Georgia
    De Vito, Francesca
    Musella, Alessandra
    Gentile, Antonietta
    Bullitta, Silvia
    Fresegna, Diego
    Sepman, Helena
    Di Sanza, Claudio
    Haji, Nabila
    Mori, Francesco
    Buttari, Fabio
    Perlas, Emerald
    Ciotti, Maria Teresa
    Hornstein, Eran
    Bozzoni, Irene
    Presutti, Carlo
    Centonze, Diego
    JOURNAL OF NEUROSCIENCE, 2017, 37 (03): : 546 - 561
  • [34] miR-142-3p Contributes to Early Cardiac Fate Decision of Embryonic Stem Cells
    Chen, Zhong-Yan
    Chen, Fei
    Cao, Nan
    Zhou, Zhi-Wen
    Yang, Huang-Tian
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [35] Platelet-derived miR-142-3p induces apoptosis of endothelial cells in hypertension
    Bao, H.
    Yao, Q-P.
    Huang, K.
    Chen, X-H.
    Han, Y.
    Jiang, Z-L.
    Gao, L-Z.
    Qi, Y-X.
    CELLULAR AND MOLECULAR BIOLOGY, 2017, 63 (04) : 3 - 9
  • [36] miR-24, miR-30b, and miR-142-3p Regulate Phagocytosis in Myeloid Inflammatory Cells
    Naqvi, Afsar Raza
    Fordham, Jezrom B.
    Nares, Salvador
    JOURNAL OF IMMUNOLOGY, 2015, 194 (04): : 1916 - 1927
  • [37] miR-142-3p is a regulator of the TGFβ-mediated vascular smooth muscle cell phenotype
    Kang, Hara
    Kim, Sunghwan
    FASEB JOURNAL, 2015, 29
  • [38] miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis
    Sonda, Nada
    Simonato, Francesca
    Peranzoni, Elisa
    Cali, Bianca
    Bortoluzzi, Stefania
    Bisognin, Andrea
    Wang, Ena
    Marincola, Francesco M.
    Naldini, Luigi
    Gentner, Bernhard
    Trautwein, Christian
    Sackett, Sara Dutton
    Zanovello, Paola
    Molon, Barbara
    Bronte, Vincenzo
    IMMUNITY, 2013, 38 (06) : 1236 - 1249
  • [39] MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p
    Liu, Ke
    Huang, Jun
    Ni, Jiangdong
    Song, Deye
    Ding, Muliang
    Wang, Junjie
    Huang, Xianzhe
    Li, Wenzhao
    CELL CYCLE, 2017, 16 (06) : 578 - 587
  • [40] Reduced serum miR-142-3p predicates worse prognosis in patients with cervical cancer
    Lu, Jiahui
    Hang, Qi
    Cui, Yulan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3637 - 3643